Picture of Mesoblast logo

MSB Mesoblast Balance Sheet

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapValue Trap

Annual balance sheet for Mesoblast, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Cash and Short Term Investments501291366070.9
Net Total Accounts Receivable
Net Total Receivables4.061.574.844.47
Prepaid Expenses
Total Other Current Assets
Total Current Assets62.513714869.881.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.82610.312.19.966.49
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets652734745662669
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities44.390.194.351.442
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities171184163165168
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity481549581497502
Total Liabilities & Shareholders' Equity652734745662669
Total Common Shares Outstanding